Equitable Holdings, Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1333986
NEW YORK, NY
Position in REGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,413,158
+$483,055 QoQ
Shares Held
1,829
+51.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
18 quarters on record
Voting authority
Sole 68.01530891197376.ToString("F0")%
Shared 0.ToString("F0")%
None 31.984691088026246.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Equitable Holdings, Inc. holds $7,394,893 across 13 Biotechnology names. REGN ranks #3 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
9,853 | $1,967,151 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,464 | $1,546,814 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,829 | $1,413,158 | |
| 4 | EXEL |
Exelixis, Inc.
|
20,600 | $883,534 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
21,135 | $687,732 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
12,291 | $584,682 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
15,500 | $118,885 | |
| 8 | DRTS |
Alpha Tau Medical Ltd.
|
10,000 | $70,700 |
All Filings in REGN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,413,158 | 1,829 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $930,103 | 1,205 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $473,431 | 842 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $462,525 | 881 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $586,662 | 925 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $633,261 | 889 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,162,671 | 1,106 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,129,857 | 1,075 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $981,739 | 1,020 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $870,385 | 991 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $790,864 | 961 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $709,917 | 988 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $794,554 | 967 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $687,579 | 953 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $441,565 | 641 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $400,786 | 678 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $504,957 | 723 | Shares | Defined | 2022-05-13 | |
| 2021-09-30 | $277,172 | 458 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||